Global Patent Index - EP 1087790 A2

EP 1087790 A2 2001-04-04 - USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY

Title (en)

USE OF A COMPOUND HAVING AFFINITY FOR THE BENZODIAZEPINE MITOCHONDRIAL RECEPTOR IN CANCER THERAPY

Title (de)

VERWENDUNG EINER VERBINDUNG MIT HOHER AFFINITÄT FÜR DEN MITOCHONDRIALEN BENZODIAZEPINE REZEPTOR IN EINEM ARZNEIMITTEL ZUR KREBS-THERAPIE

Title (fr)

UTILISATION D'UN COMPOSE POSSEDANT UNE AFFINITE POUR LE RECEPTEUR MITOCHONDRIAL DES BENZODIAZEPINES DANS UN MEDICAMENT POUR LA THERAPIE DU CANCER

Publication

EP 1087790 A2 (FR)

Application

EP 99923718 A

Priority

  • FR 9901383 W
  • FR 9807864 A

Abstract (en)

[origin: FR2779963A1] A Composition for treating cancer comprises a compound (A) with affinity for mitochondrial benzodiazepine receptors and an agent to induce apoptosis, for simultaneous, separate, or sustained use.

IPC 1-7 (main, further and additional classification)

A61K 45/06

IPC 8 full level (invention and additional information)

A61K 31/47 (2006.01); A61K 45/06 (2006.01)

CPC (invention and additional information)

A61K 45/06 (2013.01); A61K 31/47 (2013.01)

Combination set (CPC)

A61K 31/47 + A61K 2300/00

Citation (search report)

See references of WO 9966958A3

Designated contracting state (EPC)

DE FR GB IT

EPO simple patent family

FR 2779963 A1 19991224; AU 3508999 A 20000106; CA 2274741 A1 19991222; EP 1087790 A2 20010404; US 6319931 B1 20011120; WO 9966958 A2 19991229; WO 9966958 A3 20000420

INPADOC legal status


2002-06-05 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20011205

2001-07-11 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20010525

2001-04-04 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010108

2001-04-04 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): DE FR GB IT